When asked their opinions on this latest announcement from Fraunhofer CMB, members of Delaware ™s Congressional delegation made the following comments.

"Fraunhofer ™s work to help fight the spread of the H1N1 influenza virus is on the cutting edge of research and will impact the way we develop vaccines long-term," said Congressman Mike Castle. "Dr. Yusibov and his team are leaders in their field and we are lucky to have them here in Delaware."

Receiving this competitive grant shows clearly that Fraunhofer is helping lead the way in creating vaccine technology that can protect us against dangerous threats such as bioterrorism and pandemic flu, said Sens. Thomas Carper (D-Del.) and Edward (Ted) Kaufman (D-Del.). We are proud of the work being done at Fraunhofer and look forward to seeing all that they will accomplish with this additional support from the federal government.

SOURCE Fraunhofer USA Center for Molecular Biotechnology